Zhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY, 10987, USA.
Zhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Cancer Lett. 2018 Nov 1;436:38-51. doi: 10.1016/j.canlet.2018.08.013. Epub 2018 Aug 16.
ChlA-F is a novel conformation-derivative of Cheliensisin A, styryl-lactone isolates that show potent anti-tumor potential in vivo and vitro. However, the anti-cancer activity and its potential mechanisms underlying ChlA-F action have never been explored. In the present study, we evaluated the potency of ChlA-F on autophagy-mediated anchorage-independent growth inhibition in human high-grade invasive bladder cancer (BC) cells. We found that ChlA-F treatment significantly inhibited anchorage-independent growth of human BC cells by inducing autophagy in a Sestrin-2 (SESN2)-dependent fashion. Our results revealed that ChlA-F treatment specifically induced SESN2 expression via increasing its transcription and mRNA stability. On one hand, ChlA-F treatment markedly attenuated Dicer protein abundance, in turn abolishing miR-27a maturation and further relieving miR-27a binding directly to SESN2 mRNA 3'UTR, thereby promoting SESN2 mRNA stabilization. On the other hand, ChlA-F treatment promoted Sp1 abundance and consequently mediated SESN2 transcription. These results demonstrate that its activation of the autophagic pathway through specifically promoting SESN2 expression mediates the anti-cancer effect of ChlA-F, which offers insights into the novel anti-cancer effect of ChlA-F on BC, as well as providing therapeutic alternatives against human BC.
ChlA-F 是一种新型的 Cheliensisin A 构象衍生物,是一种具有潜在抗肿瘤活性的苯乙烯内酯类化合物,在体内和体外均表现出很强的抗肿瘤活性。然而,ChlA-F 的抗癌活性及其潜在作用机制尚未得到探索。在本研究中,我们评估了 ChlA-F 对人高级浸润性膀胱癌(BC)细胞中自噬介导的无锚定生长抑制的作用。我们发现,ChlA-F 通过依赖 Sestrin-2(SESN2)的方式诱导自噬,显著抑制人 BC 细胞的无锚定生长。我们的结果表明,ChlA-F 治疗通过增加 SESN2 的转录和 mRNA 稳定性,特异性地诱导 SESN2 的表达。一方面,ChlA-F 治疗显著降低了 Dicer 蛋白的丰度,从而消除了 miR-27a 的成熟,并进一步解除了 miR-27a 对 SESN2 mRNA 3'UTR 的直接结合,从而促进了 SESN2 mRNA 的稳定。另一方面,ChlA-F 治疗促进了 Sp1 的丰度,从而介导了 SESN2 的转录。这些结果表明,它通过特异性促进 SESN2 的表达激活自噬途径,介导了 ChlA-F 的抗癌作用,为 ChlA-F 对 BC 的新的抗癌作用提供了深入的了解,并为治疗人类 BC 提供了新的选择。